United Therapeutics Corporation (UTHR)
USD 294.6
(0.26%)
USD 294.6
(0.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 700 Million USD | -12.5% |
| 2022 | 800 Million USD | 0.0% |
| 2021 | 800 Million USD | 0.0% |
| 2020 | 800 Million USD | -5.88% |
| 2019 | 850 Million USD | 240.0% |
| 2018 | 250 Million USD | 0.0% |
| 2017 | 250 Million USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 5.38 Million USD | -95.74% |
| 2014 | 126.48 Million USD | -55.8% |
| 2013 | 286.18 Million USD | 4.06% |
| 2012 | 275.01 Million USD | 41.63% |
| 2011 | 194.18 Million USD | -36.31% |
| 2010 | 304.89 Million USD | 21.67% |
| 2009 | 250.59 Million USD | -10.26% |
| 2008 | 279.23 Million USD | 11.69% |
| 2007 | 250.01 Million USD | -0.0% |
| 2006 | 250.02 Million USD | 1086965.22% |
| 2005 | 23 Thousand USD | -11.54% |
| 2004 | 26 Thousand USD | -96.74% |
| 2003 | 798 Thousand USD | -57.51% |
| 2002 | 1.87 Million USD | -3.11% |
| 2001 | 1.93 Million USD | 1.65% |
| 2000 | 1.9 Million USD | 0.36% |
| 1999 | 1.9 Million USD | 533.33% |
| 1998 | 300 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 600 Million USD | -14.29% |
| 2024 Q3 | 400 Million USD | -20.0% |
| 2024 Q2 | 500 Million USD | -16.67% |
| 2023 Q2 | 800 Million USD | 0.0% |
| 2023 Q1 | 800 Million USD | 0.0% |
| 2023 FY | 700 Million USD | -12.5% |
| 2023 Q4 | 700 Million USD | 40.0% |
| 2023 Q3 | 500 Million USD | -37.5% |
| 2022 Q3 | 800 Million USD | 0.0% |
| 2022 Q4 | 800 Million USD | 0.0% |
| 2022 FY | 800 Million USD | 0.0% |
| 2022 Q1 | 800 Million USD | 0.0% |
| 2022 Q2 | 800 Million USD | 0.0% |
| 2021 Q4 | 800 Million USD | 0.0% |
| 2021 FY | 800 Million USD | 0.0% |
| 2021 Q1 | 800 Million USD | 0.0% |
| 2021 Q2 | 800 Million USD | 0.0% |
| 2021 Q3 | 800 Million USD | 0.0% |
| 2020 Q4 | 800 Million USD | 0.0% |
| 2020 Q3 | 800 Million USD | 0.0% |
| 2020 Q1 | 800 Million USD | -5.88% |
| 2020 Q2 | 800 Million USD | 0.0% |
| 2020 FY | 800 Million USD | -5.88% |
| 2019 Q3 | 1 Billion USD | -4.76% |
| 2019 Q4 | 850 Million USD | -15.0% |
| 2019 FY | 850 Million USD | 240.0% |
| 2019 Q1 | 1.05 Billion USD | 320.0% |
| 2019 Q2 | 1.05 Billion USD | 0.0% |
| 2018 Q2 | 250 Million USD | 0.0% |
| 2018 Q1 | 250 Million USD | 0.0% |
| 2018 FY | 250 Million USD | 0.0% |
| 2018 Q4 | 250 Million USD | 0.0% |
| 2018 Q3 | 250 Million USD | 0.0% |
| 2017 Q2 | 250 Million USD | 0.0% |
| 2017 FY | 250 Million USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | 250 Million USD | 0.0% |
| 2017 Q4 | 250 Million USD | 0.0% |
| 2016 Q1 | 5.4 Million USD | 0.24% |
| 2016 FY | - USD | -100.0% |
| 2016 Q2 | 900 Thousand USD | -83.33% |
| 2016 Q3 | - USD | -100.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q4 | 5.38 Million USD | -82.05% |
| 2015 Q2 | 32.28 Million USD | -71.98% |
| 2015 Q1 | 115.22 Million USD | -8.9% |
| 2015 FY | 5.38 Million USD | -95.74% |
| 2015 Q3 | 30.01 Million USD | -7.02% |
| 2014 Q4 | 126.48 Million USD | -56.58% |
| 2014 Q3 | 291.31 Million USD | -19.82% |
| 2014 Q2 | 363.32 Million USD | 25.7% |
| 2014 Q1 | 289.05 Million USD | 1.0% |
| 2014 FY | 126.48 Million USD | -55.8% |
| 2013 Q3 | 283.26 Million USD | 0.99% |
| 2013 FY | 286.18 Million USD | 4.06% |
| 2013 Q4 | 286.18 Million USD | 1.03% |
| 2013 Q2 | 280.48 Million USD | 1.0% |
| 2013 Q1 | 277.69 Million USD | 0.98% |
| 2012 FY | 275.01 Million USD | 41.63% |
| 2012 Q3 | 273.37 Million USD | 0.96% |
| 2012 Q1 | 268.16 Million USD | 38.1% |
| 2012 Q4 | 275.01 Million USD | 0.6% |
| 2012 Q2 | 270.75 Million USD | 0.97% |
| 2011 Q1 | 309 Million USD | 1.35% |
| 2011 FY | 194.18 Million USD | -36.31% |
| 2011 Q4 | 194.18 Million USD | -38.83% |
| 2011 Q3 | 317.46 Million USD | 1.36% |
| 2011 Q2 | 313.19 Million USD | 1.36% |
| 2010 FY | 304.89 Million USD | 21.67% |
| 2010 Q1 | 254.69 Million USD | 1.63% |
| 2010 Q4 | 304.89 Million USD | 15.89% |
| 2010 Q3 | 263.08 Million USD | 1.63% |
| 2010 Q2 | 258.85 Million USD | 1.63% |
| 2009 Q1 | 238.75 Million USD | -14.5% |
| 2009 FY | 250.59 Million USD | -10.26% |
| 2009 Q4 | 250.59 Million USD | 1.63% |
| 2009 Q3 | 246.58 Million USD | 1.63% |
| 2009 Q2 | 242.63 Million USD | 1.62% |
| 2008 Q4 | 279.23 Million USD | 11.71% |
| 2008 FY | 279.23 Million USD | 11.69% |
| 2008 Q1 | 250 Million USD | -0.01% |
| 2008 Q2 | 249.97 Million USD | -0.01% |
| 2008 Q3 | 249.97 Million USD | 0.0% |
| 2007 Q1 | 250.02 Million USD | -0.0% |
| 2007 Q4 | 250.01 Million USD | -0.0% |
| 2007 Q2 | 250.02 Million USD | -0.0% |
| 2007 FY | 250.01 Million USD | -0.0% |
| 2007 Q3 | 250.01 Million USD | -0.0% |
| 2006 FY | 250.02 Million USD | 1086965.22% |
| 2006 Q4 | 250.02 Million USD | 2777955.56% |
| 2006 Q3 | 9000.00 USD | -35.71% |
| 2006 Q2 | 14 Thousand USD | -26.32% |
| 2006 Q1 | 19 Thousand USD | -17.39% |
| 2005 Q1 | 20 Thousand USD | -23.08% |
| 2005 Q2 | 809 Thousand USD | 3945.0% |
| 2005 Q3 | 595 Thousand USD | -26.45% |
| 2005 Q4 | 23 Thousand USD | -96.13% |
| 2005 FY | 23 Thousand USD | -11.54% |
| 2004 Q1 | 42 Thousand USD | -94.74% |
| 2004 FY | 26 Thousand USD | -96.74% |
| 2004 Q4 | 26 Thousand USD | -16.13% |
| 2004 Q3 | 31 Thousand USD | -13.89% |
| 2004 Q2 | 36 Thousand USD | -14.29% |
| 2003 Q2 | 2.83 Million USD | -0.32% |
| 2003 FY | 798 Thousand USD | -57.51% |
| 2003 Q3 | 2.5 Million USD | -11.47% |
| 2003 Q4 | 798 Thousand USD | -68.19% |
| 2003 Q1 | 2.84 Million USD | 51.38% |
| 2002 Q2 | 1.9 Million USD | -0.63% |
| 2002 Q1 | 1.91 Million USD | -1.04% |
| 2002 Q3 | 1.89 Million USD | -0.73% |
| 2002 Q4 | 1.87 Million USD | -0.74% |
| 2002 FY | 1.87 Million USD | -3.11% |
| 2001 Q4 | 1.93 Million USD | -1.22% |
| 2001 Q3 | 1.96 Million USD | 2.05% |
| 2001 FY | 1.93 Million USD | 1.65% |
| 2001 Q1 | 1.92 Million USD | 0.79% |
| 2001 Q2 | 1.92 Million USD | 0.05% |
| 2000 Q1 | 1.82 Million USD | -4.2% |
| 2000 FY | 1.9 Million USD | 0.36% |
| 2000 Q3 | 1.79 Million USD | -0.89% |
| 2000 Q4 | 1.9 Million USD | 6.4% |
| 2000 Q2 | 1.8 Million USD | -0.67% |
| 1999 Q2 | 700 Thousand USD | 133.33% |
| 1999 Q4 | 1.9 Million USD | 5.56% |
| 1999 FY | 1.9 Million USD | 533.33% |
| 1999 Q3 | 1.8 Million USD | 157.14% |
| 1999 Q1 | 300 Thousand USD | 0.0% |
| 1998 FY | 300 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -492857.746% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -9041.488% |
| XOMA Corporation | 124.45 Million USD | -462.475% |
| Mesoblast Limited | 118.92 Million USD | -488.616% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -205.422% |
| Aptorum Group Limited | 3.36 Million USD | -20718.482% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -53778.647% |
| HilleVax, Inc. | 51.19 Million USD | -1267.374% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -2695.304% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -3251.811% |
| Precision BioSciences, Inc. | 31.26 Million USD | -2138.711% |
| Dyadic International, Inc. | 136.92 Thousand USD | -511113.841% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -442937.975% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -24273.259% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -12732.264% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -327002.804% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -12699.415% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -205.101% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -5534.256% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1628.139% |
| Opthea Limited | 200.62 Million USD | -248.903% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1252.004% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -12862.963% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -7033.394% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -11254.42% |
| NextCure, Inc. | 6.6 Million USD | -10498.032% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -112439.65% |
| Ovid Therapeutics Inc. | 46 Million USD | -1421.682% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -3195.824% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2216.653% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -1027.668% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1758.44% |
| Apollomics, Inc. | 4.66 Million USD | -14918.236% |
| PureTech Health plc | 25.51 Million USD | -2643.807% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -220025.786% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -5294.575% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -726.7% |
| ChromaDex Corporation | 3.27 Million USD | -21261.001% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -571.901% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1737.077% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -568.098% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -576.093% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -590.444% |
| Fortress Biotech, Inc. | 88.59 Million USD | -690.139% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -1008.174% |
| Celcuity Inc. | 37.44 Million USD | -1769.344% |
| ContextLogic Inc. | 6 Million USD | -11566.667% |
| GH Research PLC | 343 Thousand USD | -203981.633% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -10572.359% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1891791.892% |
| ImmuCell Corporation | 11.96 Million USD | -5748.294% |
| Amarin Corporation plc | 8.73 Million USD | -7911.903% |
| TG Therapeutics, Inc. | 110.79 Million USD | -531.797% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1101.078% |
| Acelyrin, Inc. | 1.19 Million USD | -58526.466% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -2377.087% |
| Novavax, Inc. | 280.63 Million USD | -149.434% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -403.488% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 87.924% |
| AnaptysBio, Inc. | 17.81 Million USD | -3829.494% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -12870.169% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -5168.704% |
| AbCellera Biologics Inc. | 77.38 Million USD | -804.627% |
| CorMedix Inc. | 667.63 Thousand USD | -104748.18% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -6289.776% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 74.102% |
| Aptose Biosciences Inc. | 1 Million USD | -69220.246% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -8086776.155% |
| Soligenix, Inc. | 3.49 Million USD | -19931.128% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1353.156% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -507.792% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -155258.423% |
| Kura Oncology, Inc. | 17.2 Million USD | -3969.767% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -10036.114% |
| Ardelyx, Inc. | 55.98 Million USD | -1150.402% |
| Ainos, Inc. | 5.96 Million USD | -11637.963% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -657.305% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -32458.14% |
| Prothena Corporation plc | 11.83 Million USD | -5814.66% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -4909.303% |
| Autolus Therapeutics plc | 52.96 Million USD | -1221.578% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -2673.925% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1572.92% |
| Celularity Inc. | 65.41 Million USD | -970.058% |
| Rallybio Corporation | 392 Thousand USD | -178471.429% |
| GRI Bio, Inc. | 14 Thousand USD | -4999900.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -106.929% |
| INmune Bio, Inc. | 10.43 Million USD | -6606.908% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -289.694% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -11750.229% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -856902.938% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -84559.259% |
| Humacyte, Inc. | 58.1 Million USD | -1104.695% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1109.566% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -45.578% |
| Immunocore Holdings plc | 84.03 Million USD | -733.016% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -37676.579% |
| Verastem, Inc. | 41.55 Million USD | -1584.433% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -6055.47% |
| Histogen Inc. | 4.62 Million USD | -15044.959% |
| Surrozen, Inc. | 3.37 Million USD | -20616.188% |
| Blueprint Medicines Corporation | 774.12 Million USD | 9.575% |
| Organovo Holdings, Inc. | 1.39 Million USD | -50115.208% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -27967.362% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -1206796.552% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -727.541% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -334796.182% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -13849.781% |
| Summit Therapeutics Inc. | 106.09 Million USD | -559.761% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -534.299% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -431154.89% |
| Turnstone Biologics Corp. | 3.21 Million USD | -21679.714% |
| Pulmatrix, Inc. | 8.75 Million USD | -7894.518% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -283300.81% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -617.162% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -4954.152% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -506.87% |
| Cytokinetics, Incorporated | 755.77 Million USD | 7.379% |
| Exelixis, Inc. | 189.94 Million USD | -268.53% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2186.536% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -531.04% |
| Evogene Ltd. | 1.13 Million USD | -61411.424% |
| Replimune Group, Inc. | 75.86 Million USD | -822.643% |
| PDS Biotechnology Corporation | 23.85 Million USD | -2834.812% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1268820.511% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -25025.628% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -871327.149% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1432271.598% |
| BioLineRx Ltd. | 11.59 Million USD | -5939.168% |
| Avid Bioservices, Inc. | 207.83 Million USD | -236.807% |
| Insmed Incorporated | 1.2 Billion USD | 41.86% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -32918.868% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1429.286% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -1076823.077% |
| MediWound Ltd. | 6.71 Million USD | -10330.636% |
| MiMedx Group, Inc. | 48.09 Million USD | -1355.332% |
| OmniAb, Inc. | 25.56 Million USD | -2638.547% |
| Alector, Inc. | 38.91 Million USD | -1698.654% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -227.201% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -68.664% |
| Mereo BioPharma Group plc | 5.95 Million USD | -11660.753% |
| Zai Lab Limited | 15.15 Million USD | -4520.157% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -46.311% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -42713.456% |
| Aura Biosciences, Inc. | 19.55 Million USD | -3479.281% |
| Immunic, Inc. | 1.33 Million USD | -52373.763% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -2453.347% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -2105.975% |
| Veracyte, Inc. | 12.63 Million USD | -5442.359% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -8.55% |
| FibroGen, Inc. | 170.45 Million USD | -310.666% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -7608.402% |
| Allakos Inc. | 41.46 Million USD | -1588.171% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1638.31% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -6368.903% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -463476.159% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -42746.318% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -343187.022% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -16421.123% |
| Precigen, Inc. | 7.09 Million USD | -9763.323% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 58.284% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -9466.762% |
| Incyte Corporation | 38.28 Million USD | -1728.297% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -232679.319% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1521.609% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -6184.791% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -25025.628% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -193.339% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -2587.862% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -200473.066% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -2504.07% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1453.036% |
| Agenus Inc. | 350.24 Million USD | -99.86% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -654772.721% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -49230.514% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1447.44% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1521.534% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1351.409% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -426815.172% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 17.522% |
| UroGen Pharma Ltd. | 100.21 Million USD | -598.505% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -68033.284% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -283.039% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -4931561.265% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -229408.197% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -178470.517% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -10141.405% |
| Chimerix, Inc. | 2.14 Million USD | -32549.254% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -71842.446% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1868.766% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -405290.536% |
| Pluri Inc. | 29.61 Million USD | -2263.907% |
| Cue Biopharma, Inc. | 14.69 Million USD | -4663.525% |
| MeiraGTx Holdings plc | 89.26 Million USD | -684.191% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -3278588.525% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -14253.086% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -1032.356% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -572.456% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -10019.994% |
| NLS Pharmaceutics AG | 1.63 Million USD | -42746.318% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -2118.841% |
| Nutriband Inc. | 241.28 Thousand USD | -290013.351% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -12704.097% |
| Vor Biopharma Inc. | 35.66 Million USD | -1862.984% |
| Roivant Sciences Ltd. | 499.74 Million USD | -40.07% |
| ProKidney Corp. | 4.41 Million USD | -15762.225% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -56996.248% |
| Daré Bioscience, Inc. | 5.31 Million USD | -13062.484% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 59.766% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -123793.805% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1457.078% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1698.561% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -874.835% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -695.961% |
| Atai Life Sciences N.V. | 16.47 Million USD | -4148.604% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -28459.818% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -103603.704% |
| MediciNova, Inc. | 215.92 Thousand USD | -324085.138% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -27956.112% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -55410.266% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -61249.693% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -275.593% |
| Biomea Fusion, Inc. | 10.29 Million USD | -6698.757% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -1153.155% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -19398.607% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -7541.087% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -4671.318% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -5610.556% |
| bluebird bio, Inc. | 330.32 Million USD | -111.912% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -5497.313% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -42984.506% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 38.265% |
| BioAtla, Inc. | 2.46 Million USD | -28355.285% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -635.905% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -12521.709% |
| DBV Technologies S.A. | 14.38 Million USD | -4767.534% |
| Fortress Biotech, Inc. | 88.59 Million USD | -690.139% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -7005.156% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -3597.248% |
| aTyr Pharma, Inc. | 15.09 Million USD | -4537.297% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -3225.732% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -214299.696% |
| Galecto, Inc. | 249 Thousand USD | -281024.498% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -42799.386% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 53.31% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -559.979% |
| Entera Bio Ltd. | 390 Thousand USD | -179387.179% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -72.932% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -11175.773% |
| Xencor, Inc. | 83.43 Million USD | -738.987% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -41393.776% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -15087.676% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -57078.985% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -7343.641% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -426815.172% |
| Portage Biotech Inc. | 47 Thousand USD | -1489261.702% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -55410.266% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -28861.523% |
| OncoCyte Corporation | 2.86 Million USD | -24298.745% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -464849.453% |
| Purple Biotech Ltd. | 351 Thousand USD | -199330.199% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -22058.911% |
| Onconetix, Inc. | 9.88 Million USD | -6980.884% |
| MacroGenics, Inc. | 33.97 Million USD | -1960.581% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -34314.963% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -13281.763% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -5034.6% |
| Aditxt, Inc. | 18.21 Million USD | -3742.356% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -2517.997% |
| Curis, Inc. | 2.79 Million USD | -24953.686% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -32664.648% |
| Adagene Inc. | 22.3 Million USD | -3038.047% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -4083.85% |
| BeiGene, Ltd. | 930.18 Million USD | 24.746% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -233.11% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -86490.582% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -14.572% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -920952.632% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -27877.618% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -753.483% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -239.944% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -14973.213% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 73.906% |
| ADMA Biologics, Inc. | 141.41 Million USD | -394.986% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -1055.516% |
| Clene Inc. | 32.16 Million USD | -2076.549% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -27437.372% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -3612.937% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -31790.661% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1281.434% |
| Adicet Bio, Inc. | 20.92 Million USD | -3245.441% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -262.334% |
| Absci Corporation | 15.95 Million USD | -4286.789% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -4474.266% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -3349.465% |
| Surrozen, Inc. | 3.37 Million USD | -20616.188% |
| Generation Bio Co. | 97.89 Million USD | -615.059% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -212665.957% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -2446.844% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -2667.017% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -2752.253% |
| Invivyd, Inc. | 2.16 Million USD | -32232.564% |
| Cingulate Inc. | 3.13 Million USD | -22227.844% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1209.243% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -19865213.177% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -139647.616% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -12528.541% |
| Jaguar Health, Inc. | 35.86 Million USD | -1852.036% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1111011.111% |
| 2seventy bio, Inc. | 256.67 Million USD | -172.721% |
| Clearside Biomedical, Inc. | 43 Million USD | -1527.869% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -115986.235% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1123.669% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -12372.929% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -145356.057% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -2375.948% |
| Innoviva, Inc. | 449.07 Million USD | -55.876% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -3362.09% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -925.942% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -3970.477% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -462.068% |
| Evaxion Biotech A/S | 10.86 Million USD | -6339.933% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -739.439% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -834.492% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -10675.862% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1707217.073% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -2493.553% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -150437.634% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -2452.043% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -6754.01% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -19579.505% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -44916.077% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -55455.556% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -4746.303% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -77162.693% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1253.232% |
| ImmunityBio, Inc. | 883.67 Million USD | 20.786% |
| Korro Bio, Inc. | 33.2 Million USD | -2007.989% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -886.249% |
| Kineta, Inc. | 1.31 Million USD | -53051.101% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -298444.383% |
| BioVie Inc. | 6.11 Million USD | -11353.916% |
| Codexis, Inc. | 22.36 Million USD | -3030.03% |
| Celularity Inc. | 65.41 Million USD | -970.058% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -182667.624% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -311982.033% |
| Kodiak Sciences Inc. | 181.63 Million USD | -285.395% |
| Cibus, Inc. | 24.62 Million USD | -2743.101% |
| Annexon, Inc. | 31.35 Million USD | -2132.499% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -29788.984% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 51.842% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -832.886% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -17834.922% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -4245.732% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -527.859% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1420.45% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -2079.463% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -70965.99% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -6009.802% |
| Alkermes plc | 290.73 Million USD | -140.773% |
| Arcellx, Inc. | 97.62 Million USD | -617.029% |
| Moolec Science SA | 2.64 Million USD | -26362.137% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -32473.29% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -10988.231% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -2540.214% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -22466.086% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -29042.381% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -40292.383% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -1104.695% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -2357.261% |
| Geron Corporation | 85.89 Million USD | -714.911% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1438.123% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 88.591% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -607254.192% |
| Notable Labs, Ltd. | 2.04 Million USD | -34063.006% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1969.169% |
| Structure Therapeutics Inc. | 5.45 Million USD | -12736.968% |
| IN8bio, Inc. | 4.89 Million USD | -14206.152% |
| 89bio, Inc. | 27.1 Million USD | -2482.264% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -174900.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1203.344% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -27688.805% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -52216.891% |
| Liquidia Corporation | 3.5 Million USD | -19882.872% |
| Mustang Bio, Inc. | 2.49 Million USD | -27922.418% |
| Immunovant, Inc. | 138 Thousand USD | -507146.377% |
| Vericel Corporation | 88.14 Million USD | -694.164% |
| Quantum-Si incorporated | 15.3 Million USD | -4474.266% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -7926.602% |
| XOMA Corporation | 124.45 Million USD | -462.475% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -255374.453% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -856902.938% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -5172.672% |
| Vaxcyte, Inc. | 29.22 Million USD | -2295.292% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -6320.251% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -344727.586% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -3288.026% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -42247.247% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -55455.556% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -173597.27% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -67729.457% |
| PepGen Inc. | 20.1 Million USD | -3381.894% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -121851.22% |
| Solid Biosciences Inc. | 26.26 Million USD | -2565.144% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -70965.99% |
| Immuneering Corporation | 4.46 Million USD | -15584.661% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -692969.307% |
| Belite Bio, Inc | 886 Thousand USD | -78906.772% |
| Pharming Group N.V. | 171.54 Million USD | -308.056% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -192.132% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -3181.609% |
| uniQure N.V. | 138.4 Million USD | -405.747% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -4059.239% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -719.451% |
| Altimmune, Inc. | 671 Thousand USD | -104221.908% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -5172.672% |
| Peak Bio, Inc. | 10.72 Million USD | -6428.75% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -7608.402% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -39968.689% |
| Benitec Biopharma Inc. | 284 Thousand USD | -246378.873% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -57.283% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -241576.823% |
| Compugen Ltd. | 1.35 Million USD | -51713.472% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -332458.946% |
| argenx SE | 20 Million USD | -3400.0% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1536.814% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -727.864% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -3413.88% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -497.305% |
| PolyPid Ltd. | 11.77 Million USD | -5842.78% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -665.379% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -16642.406% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -119558.12% |
| Instil Bio, Inc. | 86.05 Million USD | -713.443% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2222.726% |
| Immunome, Inc. | 1.65 Million USD | -42324.242% |
| Verona Pharma plc | 51.32 Million USD | -1263.751% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -7058.928% |
| Shattuck Labs, Inc. | 4.2 Million USD | -16558.734% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -193270.166% |
| Design Therapeutics, Inc. | 3.05 Million USD | -22850.82% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -267075.573% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -4819.876% |
| Achilles Therapeutics plc | 4.61 Million USD | -15067.931% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -87.306% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2225.659% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -18829.837% |
| Beam Therapeutics Inc. | 173.17 Million USD | -304.22% |
| Moolec Science SA | 2.64 Million USD | -26362.137% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -147268.421% |
| AEON Biopharma, Inc. | 278 Thousand USD | -251698.561% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -9865.831% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -208855.224% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -822.728% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -1045.532% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2217.172% |
| Athira Pharma, Inc. | 1.58 Million USD | -44064.038% |
| HCW Biologics Inc. | 6.45 Million USD | -10749.724% |
| XOMA Corporation | 124.45 Million USD | -462.475% |
| NeurAxis, Inc. | 224.26 Thousand USD | -312037.697% |
| Lumos Pharma, Inc. | 6.58 Million USD | -10530.22% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -7058.928% |
| 180 Life Sciences Corp. | 1.32 Million USD | -52927.531% |
| Nektar Therapeutics | 230.4 Million USD | -203.818% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -3413.88% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -3998.331% |
| Arvinas, Inc. | 3.4 Million USD | -20488.235% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -44916.077% |
| Palisade Bio, Inc. | 369 Thousand USD | -189601.897% |
| Nutriband Inc. | 241.28 Thousand USD | -290013.351% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -42799.386% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -84645.763% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -168574.699% |
| Merus N.V. | 12.16 Million USD | -5655.632% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -445.052% |
| Neurogene Inc. | 16.25 Million USD | -4206.367% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -127.168% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2352.612% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -4967.323% |
| Rezolute, Inc. | 2.22 Million USD | -31318.312% |
| Clene Inc. | 32.16 Million USD | -2076.549% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -399778.894% |
| BeyondSpring Inc. | 3.99 Million USD | -17421.902% |
| Synlogic, Inc. | 17.27 Million USD | -3952.098% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -53746.154% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1999900.0% |
| Peak Bio, Inc. | 10.72 Million USD | -6428.75% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1248.15% |
| Krystal Biotech, Inc. | 8.09 Million USD | -8548.383% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -295.444% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -9819.229% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -512367.605% |
| MannKind Corporation | 382.37 Million USD | -83.064% |
| Ikena Oncology, Inc. | 10.73 Million USD | -6418.905% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -171049.144% |
| Gossamer Bio, Inc. | 212.46 Million USD | -229.468% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -402198.851% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -7541.087% |
| Legend Biotech Corporation | 328.67 Million USD | -112.978% |
| Mural Oncology plc | 15 Million USD | -4563.868% |
| Disc Medicine, Inc. | 2.1 Million USD | -33217.468% |
| Champions Oncology, Inc. | 7.43 Million USD | -9321.265% |
| REGENXBIO Inc. | 89.29 Million USD | -683.962% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -81800.369% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -126486.399% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -12829.442% |
| Vaxart, Inc. | 26.51 Million USD | -2540.115% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -4370.741% |
| Cellectis S.A. | 92.85 Million USD | -653.88% |
| Longeveron Inc. | 2.04 Million USD | -34196.913% |
| Repare Therapeutics Inc. | 3.41 Million USD | -20427.859% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 49.886% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1402.404% |
| Revolution Medicines, Inc. | 87.94 Million USD | -695.961% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -404524.277% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -17608.07% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -220720.189% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -399900.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 13.409% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1239.944% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -4759.268% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -50846.143% |
| Cingulate Inc. | 3.13 Million USD | -22227.844% |
| Passage Bio, Inc. | 26.29 Million USD | -2562.204% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -10402.626% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -171468.627% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -78199.776% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -3304.504% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -28458.362% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -22314.345% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -86213.194% |
| OmniAb, Inc. | 25.56 Million USD | -2638.547% |
| Anew Medical, Inc. | 1.6 Million USD | -43513.707% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -2266.235% |
| Lipocine Inc. | 17.16 Thousand USD | -4077728.265% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -5914.779% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1921.486% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -11750.229% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1124.354% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -344727.586% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -13452.759% |
| Ocugen, Inc. | 6.94 Million USD | -9985.002% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4854.349% |
| Q32 Bio Inc. | 1.31 Million USD | -53010.774% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -104066.667% |
| Alumis Inc. Common Stock | 32.58 Million USD | -2048.557% |
| Equillium, Inc. | 824 Thousand USD | -84851.456% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -7610.1% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -232608.124% |
| Dominari Holdings Inc. | 3.02 Million USD | -23017.569% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -740742.656% |
| vTv Therapeutics Inc. | 529 Thousand USD | -132225.142% |
| Bio-Techne Corporation | 419.53 Million USD | -66.85% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -872.276% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -261.634% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -4044.955% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2975.301% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -11454.969% |
| Nkarta, Inc. | 88.33 Million USD | -692.402% |
| BioCardia, Inc. | 1.31 Million USD | -53131.939% |
| Iterum Therapeutics plc | 19.5 Million USD | -3488.088% |